Interleukin 6 protects pancreatic b cells from apoptosis by stimulation of autophagy

Amelia Linnemann, Joseph Blumer, Michelle R. Marasco, Therese J. Battiola, Heidi M. Umhoefer, Jee Young Han, Dudley W. Lamming, Dawn Belt Davis

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

IL-6 is a pleiotropic cytokine with complex roles in inflammation and metabolic disease. The role of IL-6 as a pro- or anti-inflammatory cytokine is still unclear. Within the pancreatic islet, IL-6 stimulates secretion of the prosurvival incretin hormone glucagon-like peptide 1 (GLP-1) by α cells and acts directly on β cells to stimulate insulin secretion in vitro. Uncovering physiologic mechanisms promoting β-cell survival under conditions of inflammation and stress can identify important pathways for diabetes prevention and treatment. Given the established role of GLP-1 in promoting β-cell survival, we hypothesized that IL-6 may also directly protect β cells from apoptosis. Herein, we show that IL-6 robustly activates signal transducer and activator of transcription 3 (STAT3), a transcription factor that is involved in autophagy. IL-6 stimulates LC3 conversion and autophagosome formation in cultured β cells. In vivo IL-6 infusion stimulates a robust increase in lysosomes in the pancreas that is restricted to the islet. Autophagy is critical for β-cell homeostasis, particularly under conditions of stress and increased insulin demand. The stimulation of autophagy by IL-6 is regulated via multiple complementary mechanisms including inhibition of mammalian target of rapamycin complex 1 (mTORC1) and activation of Akt, ultimately leading to increases in autophagy enzyme production. Pretreatment with IL-6 renders β cells resistant to apoptosis induced by proinflammatory cytokines, and inhibition of autophagy with chloroquine prevents the ability of IL-6 to protect from apoptosis. Importantly, we find that IL-6 can activate STAT3 and the autophagy enzyme GABARAPL1 in human islets. We also see evidence of decreased IL-6 pathway signaling in islets from donors with type 2 diabetes. On the basis of our results, we propose direct stimulation of autophagy as a novel mechanism for IL-6-mediated protection of β cells from stress-induced apoptosis.

Original languageEnglish (US)
Pages (from-to)4140-4152
Number of pages13
JournalFASEB Journal
Volume31
Issue number9
DOIs
StatePublished - Sep 1 2017

Fingerprint

Autophagy
Interleukin-6
Apoptosis
STAT3 Transcription Factor
Glucagon-Like Peptide 1
Cells
Cytokines
Medical problems
Cell Survival
Insulin
Inflammation
Incretins
Cytoprotection
Metabolic Diseases
Chloroquine
Enzymes
Lysosomes
Islets of Langerhans
Type 2 Diabetes Mellitus
Pancreas

Keywords

  • Diabetes
  • Islet
  • Pancreas

ASJC Scopus subject areas

  • Biotechnology
  • Biochemistry
  • Molecular Biology
  • Genetics

Cite this

Linnemann, A., Blumer, J., Marasco, M. R., Battiola, T. J., Umhoefer, H. M., Han, J. Y., ... Davis, D. B. (2017). Interleukin 6 protects pancreatic b cells from apoptosis by stimulation of autophagy. FASEB Journal, 31(9), 4140-4152. https://doi.org/10.1096/fj.201700061RR

Interleukin 6 protects pancreatic b cells from apoptosis by stimulation of autophagy. / Linnemann, Amelia; Blumer, Joseph; Marasco, Michelle R.; Battiola, Therese J.; Umhoefer, Heidi M.; Han, Jee Young; Lamming, Dudley W.; Davis, Dawn Belt.

In: FASEB Journal, Vol. 31, No. 9, 01.09.2017, p. 4140-4152.

Research output: Contribution to journalArticle

Linnemann, A, Blumer, J, Marasco, MR, Battiola, TJ, Umhoefer, HM, Han, JY, Lamming, DW & Davis, DB 2017, 'Interleukin 6 protects pancreatic b cells from apoptosis by stimulation of autophagy', FASEB Journal, vol. 31, no. 9, pp. 4140-4152. https://doi.org/10.1096/fj.201700061RR
Linnemann, Amelia ; Blumer, Joseph ; Marasco, Michelle R. ; Battiola, Therese J. ; Umhoefer, Heidi M. ; Han, Jee Young ; Lamming, Dudley W. ; Davis, Dawn Belt. / Interleukin 6 protects pancreatic b cells from apoptosis by stimulation of autophagy. In: FASEB Journal. 2017 ; Vol. 31, No. 9. pp. 4140-4152.
@article{f9884b0c453545e3a94efe71f32b1e0e,
title = "Interleukin 6 protects pancreatic b cells from apoptosis by stimulation of autophagy",
abstract = "IL-6 is a pleiotropic cytokine with complex roles in inflammation and metabolic disease. The role of IL-6 as a pro- or anti-inflammatory cytokine is still unclear. Within the pancreatic islet, IL-6 stimulates secretion of the prosurvival incretin hormone glucagon-like peptide 1 (GLP-1) by α cells and acts directly on β cells to stimulate insulin secretion in vitro. Uncovering physiologic mechanisms promoting β-cell survival under conditions of inflammation and stress can identify important pathways for diabetes prevention and treatment. Given the established role of GLP-1 in promoting β-cell survival, we hypothesized that IL-6 may also directly protect β cells from apoptosis. Herein, we show that IL-6 robustly activates signal transducer and activator of transcription 3 (STAT3), a transcription factor that is involved in autophagy. IL-6 stimulates LC3 conversion and autophagosome formation in cultured β cells. In vivo IL-6 infusion stimulates a robust increase in lysosomes in the pancreas that is restricted to the islet. Autophagy is critical for β-cell homeostasis, particularly under conditions of stress and increased insulin demand. The stimulation of autophagy by IL-6 is regulated via multiple complementary mechanisms including inhibition of mammalian target of rapamycin complex 1 (mTORC1) and activation of Akt, ultimately leading to increases in autophagy enzyme production. Pretreatment with IL-6 renders β cells resistant to apoptosis induced by proinflammatory cytokines, and inhibition of autophagy with chloroquine prevents the ability of IL-6 to protect from apoptosis. Importantly, we find that IL-6 can activate STAT3 and the autophagy enzyme GABARAPL1 in human islets. We also see evidence of decreased IL-6 pathway signaling in islets from donors with type 2 diabetes. On the basis of our results, we propose direct stimulation of autophagy as a novel mechanism for IL-6-mediated protection of β cells from stress-induced apoptosis.",
keywords = "Diabetes, Islet, Pancreas",
author = "Amelia Linnemann and Joseph Blumer and Marasco, {Michelle R.} and Battiola, {Therese J.} and Umhoefer, {Heidi M.} and Han, {Jee Young} and Lamming, {Dudley W.} and Davis, {Dawn Belt}",
year = "2017",
month = "9",
day = "1",
doi = "10.1096/fj.201700061RR",
language = "English (US)",
volume = "31",
pages = "4140--4152",
journal = "FASEB Journal",
issn = "0892-6638",
publisher = "FASEB",
number = "9",

}

TY - JOUR

T1 - Interleukin 6 protects pancreatic b cells from apoptosis by stimulation of autophagy

AU - Linnemann, Amelia

AU - Blumer, Joseph

AU - Marasco, Michelle R.

AU - Battiola, Therese J.

AU - Umhoefer, Heidi M.

AU - Han, Jee Young

AU - Lamming, Dudley W.

AU - Davis, Dawn Belt

PY - 2017/9/1

Y1 - 2017/9/1

N2 - IL-6 is a pleiotropic cytokine with complex roles in inflammation and metabolic disease. The role of IL-6 as a pro- or anti-inflammatory cytokine is still unclear. Within the pancreatic islet, IL-6 stimulates secretion of the prosurvival incretin hormone glucagon-like peptide 1 (GLP-1) by α cells and acts directly on β cells to stimulate insulin secretion in vitro. Uncovering physiologic mechanisms promoting β-cell survival under conditions of inflammation and stress can identify important pathways for diabetes prevention and treatment. Given the established role of GLP-1 in promoting β-cell survival, we hypothesized that IL-6 may also directly protect β cells from apoptosis. Herein, we show that IL-6 robustly activates signal transducer and activator of transcription 3 (STAT3), a transcription factor that is involved in autophagy. IL-6 stimulates LC3 conversion and autophagosome formation in cultured β cells. In vivo IL-6 infusion stimulates a robust increase in lysosomes in the pancreas that is restricted to the islet. Autophagy is critical for β-cell homeostasis, particularly under conditions of stress and increased insulin demand. The stimulation of autophagy by IL-6 is regulated via multiple complementary mechanisms including inhibition of mammalian target of rapamycin complex 1 (mTORC1) and activation of Akt, ultimately leading to increases in autophagy enzyme production. Pretreatment with IL-6 renders β cells resistant to apoptosis induced by proinflammatory cytokines, and inhibition of autophagy with chloroquine prevents the ability of IL-6 to protect from apoptosis. Importantly, we find that IL-6 can activate STAT3 and the autophagy enzyme GABARAPL1 in human islets. We also see evidence of decreased IL-6 pathway signaling in islets from donors with type 2 diabetes. On the basis of our results, we propose direct stimulation of autophagy as a novel mechanism for IL-6-mediated protection of β cells from stress-induced apoptosis.

AB - IL-6 is a pleiotropic cytokine with complex roles in inflammation and metabolic disease. The role of IL-6 as a pro- or anti-inflammatory cytokine is still unclear. Within the pancreatic islet, IL-6 stimulates secretion of the prosurvival incretin hormone glucagon-like peptide 1 (GLP-1) by α cells and acts directly on β cells to stimulate insulin secretion in vitro. Uncovering physiologic mechanisms promoting β-cell survival under conditions of inflammation and stress can identify important pathways for diabetes prevention and treatment. Given the established role of GLP-1 in promoting β-cell survival, we hypothesized that IL-6 may also directly protect β cells from apoptosis. Herein, we show that IL-6 robustly activates signal transducer and activator of transcription 3 (STAT3), a transcription factor that is involved in autophagy. IL-6 stimulates LC3 conversion and autophagosome formation in cultured β cells. In vivo IL-6 infusion stimulates a robust increase in lysosomes in the pancreas that is restricted to the islet. Autophagy is critical for β-cell homeostasis, particularly under conditions of stress and increased insulin demand. The stimulation of autophagy by IL-6 is regulated via multiple complementary mechanisms including inhibition of mammalian target of rapamycin complex 1 (mTORC1) and activation of Akt, ultimately leading to increases in autophagy enzyme production. Pretreatment with IL-6 renders β cells resistant to apoptosis induced by proinflammatory cytokines, and inhibition of autophagy with chloroquine prevents the ability of IL-6 to protect from apoptosis. Importantly, we find that IL-6 can activate STAT3 and the autophagy enzyme GABARAPL1 in human islets. We also see evidence of decreased IL-6 pathway signaling in islets from donors with type 2 diabetes. On the basis of our results, we propose direct stimulation of autophagy as a novel mechanism for IL-6-mediated protection of β cells from stress-induced apoptosis.

KW - Diabetes

KW - Islet

KW - Pancreas

UR - http://www.scopus.com/inward/record.url?scp=85028804720&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85028804720&partnerID=8YFLogxK

U2 - 10.1096/fj.201700061RR

DO - 10.1096/fj.201700061RR

M3 - Article

VL - 31

SP - 4140

EP - 4152

JO - FASEB Journal

JF - FASEB Journal

SN - 0892-6638

IS - 9

ER -